Stability of [−2]Pro-PSA in Whole Blood and Serum: Analysis for Optimal Measurement Conditions-Reference-Cited by-同舟云学术

Stability of [−2]Pro-PSA in Whole Blood and Serum: Analysis for Optimal Measurement Conditions

Published:2014-02-27 Issue:4 Volume:28 Page:315-319
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:J. Clin. Lab. Anal.

Author:

Igawa Tsukasa¹,Takehara Kosuke¹,Onita Toru¹,Ito Kazuto²,Sakai Hideki¹

Affiliation:

1. Department of Nephro-urology; Nagasaki University Graduate School of Biomedical Sciences; Nagasaki Japan

2. Department of Urology; Gunma University School of Medicine; Maebashi Japan

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry, medical,Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Reference22 articles.

1. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer;Catalona;N Engl J Med,1991

2. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6,630 men;Catalona;J Urol,1994

3. Proenzyme PSA for the early detection of prostate cancer in the 2.5-4.0 ng/ml total PSA range: Preliminary analysis;Sokoll;Urology,2003

4. Evaluation of proprostate specific antigen for early detection of prostate cancer in men with a total prostate specific antigen range of 4.0 to 10.0 ng/ml;Khan;J Urol,2003

5. Serum pro prostate specific antigen improves cancer detection compared to free and complexed prostate specific antigen in men with prostate specific antigen 2 to 4 ng/ml;Catalona;J Urol,2003

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Performance evaluation and characterization of pre-analytical effects by sample types and storage conditions on tumor marker measurement by the point-of-care test platform IchromaTM II;Clinica Chimica Acta;2024-09

2. Preanalytical stability of molecular forms of prostate‐specific antigen in serum samples (PSA, free PSA, [−2]proPSA) and their impact on fPSA/tPSA ratio and PHI;The Prostate;2024-02-27

3. A Model to Detect Significant Prostate Cancer Integrating Urinary Peptide and Extracellular Vesicle RNA Data;Cancers;2022-04-14

4. Detection of ISUP ≥2 prostate cancers using multiparametric MRI: prospective multicentre assessment of the non-inferiority of an artificial intelligence system as compared to the PI-RADS V.2.1 score (CHANGE study);BMJ Open;2022-02

5. Biomarkers for prostate cancer detection and risk stratification;Therapeutic Advances in Urology;2022-01